ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 906 • 2018 ACR/ARHP Annual Meeting

    Defining the Gut Microbiome in Patients with ANCA-Associated Vasculitis

    Catherine E. Najem1, Jung-Jin Lee2, Ceylan Tanes2, Antoine G. Sreih1, Rennie L. Rhee1, Abdallah Geara3, Hongzhe Li4, Kyle Bittinger2, James D. Lewis5 and Peter A. Merkel4,6, 1Rheumatology, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, 3Division of Nephrology and Hypertension, University of Pennsylvania, Philadelphia, PA, 4Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, 5Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA, 6Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose:Although a link between gut microbiome and autoimmune diseases has been suggested, there is a gap in the understanding of the gut microbiome in ANCA-associated…
  • Abstract Number: 907 • 2018 ACR/ARHP Annual Meeting

    Characterization of Preferential Recognition of a Chimeric Recombinant Proteinase 3 Variant By Anti-Neutrophil Cytoplasmic Antibodies

    Gwen Thompson1, Marta Casal Moura2, Darlene Nelson1, Amber Hummel1, Dieter E. Jenne3, Fernando Fervenza4, Gary S. Hoffman5, Cees G.M. Kallenberg6, Carol Langford7, Joseph W. McCune8, Peter A. Merkel9, Paul A. Monach10, Philip Seo11, Robert F. Spiera12, Eugene William St. Clair13, Steven R. Ytterberg14, John H. Stone15, William H. Robinson16, Yuan-Ping Pang1 and Ulrich Specks17, 1Mayo Clinic, Rochester, MN, 2Pulmonary and Critical Care, Thoracic Disease Research Unit, Mayo Clinic College of Medicine, Rochester, MN, 3Helmholtz Zentrum München, Munich, Germany, 4Nephrology, Mayo Clinic, Rochester, MN, 5Rheumatology, Cleveland Clinic, Cleveland, OH, 6University of Gronigen, Groningen, Netherlands, 7Rheumatic and Immunologic Diseases, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 8University of Michigan, Ann Arbor, MI, 9University of Pennsylvania, Philadelphia, PA, 10Section of Rheumatology, Boston University School of Medicine, Boston, MA, 11Medicine, Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 12Hospital for Special Surgery, New York, NY, 13Medicine, Duke University Medical Center, Durham, NC, 14Rheumatology, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, 15Rheumatology (Medicine), Massachusetts General Hospital, Harvard Medical School, Boston, MA, 16Stanford, Stanford, CA, 17Mayo Clinic College of Medicine, Rochester, MN

    Background/Purpose: Human-murine chimeric variants have been used to study specific epitope recognition by anti-neutrophil cytoplasmic antibodies (ANCAs) targeting proteinase 3 (PR3) in patients with ANCA-associated…
  • Abstract Number: 908 • 2018 ACR/ARHP Annual Meeting

    Early Prediction of Long-Term Evolutionary Profiles of Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss) Based on Baseline and Follow-up Characteristics

    Matthias Papo1, Giacomo Emmi2, Franco Schiavon3, Matthieu Groh4, Maria-Letizia Urban2, Chiara Marvisi5, Jean-Emmanuel Kahn4, Alberto Sinico6, Maxime Samson7, Pascal Cohen1, Xavier Puéchal1, Luc Mouthon1, Loïc Guillevin1, Augusto Vaglio5 and Benjamin Terrier8, 1Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, Hôpital Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France, 2Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy, 3Operative Unit of Rheumatology, Department of Medicine DIMED, University of Padova, Padova, Italy, 4Service de Médecine Interne, Centre de Référence des Syndromes Hyperéosinophiliques-CEREO, Hôpital Foch, Université Versailles–Saint-Quentin-en-Yvelines, Suresnes, France, 5Nephrology Unit, Parma University Hospital, Parma, Italy, 6UOS di Immunologia Clinica e UOC di Nefrologia, Azienda Ospedaliera San Carlo Borromeo, Milan, Italy, 7Department of Internal Medicine and Clinical Immunology, François-Mitterrand Teaching Hospital, University of Bourgogne-Franche-Comté, Dijon, France, 8Department of Internal Medicine, Centre de Référence pour les Maladies Auto-immunes Rares, Paris, France, Hôpital Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France

    Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA) (Churg–Strauss) is a small-vessel necrotizing vasculitis characterized by blood and tissue eosinophilia and asthma. Glucocorticoids (GCs) effectively control the…
  • Abstract Number: 909 • 2018 ACR/ARHP Annual Meeting

    Temporal Trends of ANCA-Associated Vasculitis Comorbidities: Results from a National, Longitudinal, Matched-Cohort Study

    Shifa Sarica1, Neeraj Dhaun2, Jan Sznajd3, John Harvie3, Nicola Joss3, John McLaren4, Lucy McGeoch5, Nicole Amft6, Vinod Kumar7, Angharad Marks1, Corri Black1 and Neil Basu1, 1Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom, 2University/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom, 3Department of Rheumatology, Raigmore Hospital, Inverness, United Kingdom, 4Fife Rheumatic Diseases Unit, Whyteman's Brae Hospital, Kirkcaldy, United Kingdom, 5Center for Rheumatic Diseases, Glasgow Royal Infirmary, Glasgow, United Kingdom, 6Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom, 7Rheumatology Department, Ninewells Hospital, Dundee, United Kingdom

    Background/Purpose: Comorbidity is common in patients with ANCA-associated vasculitis (AAV). However, this comorbidity and its burden over time remains unexplored. In this large multicenter study,…
  • Abstract Number: 910 • 2018 ACR/ARHP Annual Meeting

    In Diagnostic Prevalence and Treatment Patterns of Male and Female Ankylosing Spondylitis Patients in the United States, 2006-2016

    Jessica Walsh1, Theresa Hunter2, Rebecca Bolce2, David Sandoval Calderon2 and Krista Schroeder2, 1University of Utah School of Medicine, Salt Lake City, UT, USA, Salt Lake City, UT, 2Eli Lilly and Company, Indianapolis, IN

    Background/Purpose: This study aimed to analyze the prevalence rates and treatment patterns of male and female ankylosing spondylitis (AS) patients in the United States (US)…
  • Abstract Number: 911 • 2018 ACR/ARHP Annual Meeting

    Demographic and Clinical Characteristics Reflect Differences in Osteoarthritis Phenotypes of the Lumbar Spine: The Johnston County Osteoarthritis Project

    Adam P. Goode1, Becki Cleveland2, Todd Schwartz3, Steven Z. George4, Virginia B. Kraus5, Richard Gracely6, Jun Chen4, Joanne M. Jordan7 and Yvonne M. Golightly8, 1O, Duke University, Durham, NC, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, 4Department of Orthopedic Surgery, Duke University, Durham, NC, 5Duke Molecular Physiology Institute, Duke University, Durham, NC, 6University of North Carolina, Chapel Hill, North Carolina, Chapel Hill, NC, 7Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 8Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Spine osteoarthritis (OA) has been defined by the presence of: 1) disc space narrowing (DSN) and vertebral osteophytes (OST), or 2) facet joint OA…
  • Abstract Number: 912 • 2018 ACR/ARHP Annual Meeting

    Association of Adiposity Measures in Childhood and Adulthood with Knee Cartilage Thickness, Volume and Bone Area in Young Adults

    Tao Meng1, Alison Venn1, Felix Eckstein2,3, Wolfgang Wirth2,3, Flavia Cicuttini4, Lyn March5, Terence Dwyer1,6, Marita Cross5, Laura Laslett1, Graeme Jones1, Changhai Ding1,7 and Benny Samuel Eathakkattu Antony1, 1Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, 2Chondrometrics GmbH, Ainring, Germany, 3Institute of Anatomy, Paracelsus Medical University, Salzburg, Austria, 4Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia, 5Institute of Bone and Joint Research, University of Sydney, Sydney, Australia, 6The George Institute for Global Health, Nuffield Department of Obstetrics & Gynaecology, University of Oxford, Oxford, United Kingdom, 7Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China

    Background/Purpose: Adiposity is associated with increased risk of knee osteoarthritis; cartilage thickness, cartilage volume and subchondral bone area are established biomarkers in knee osteoarthritis. We…
  • Abstract Number: 913 • 2018 ACR/ARHP Annual Meeting

    Risk Factors for Knee Pain Exacerbation on Walking: A within-Person Knee-Matched Study

    Qiang Liu1,2, David J. Hunter3, Manuela Ferreira4, Barton L Wise5, Ke Tao1, Yuqing Zhang6 and Jianhao Lin1, 1Arthritis Clinic and Research Center, Peking University People's Hospital, Beijing, China, 2Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 3Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, 4Institute of Bone and Joint Research | The Kolling Institute, Sydney Medical School, Sydney, Australia, 5Orthopaedics, Internal Medicine, University of California, Davis School of Medicine, Sacramento, CA, 6Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA

    Background/Purpose: Pain exacerbation on walking is common among patients with knee osteoarthritis and often lead to activity avoidance. To date, few risk factors for pain…
  • Abstract Number: 914 • 2018 ACR/ARHP Annual Meeting

    Increased Adverse Childhood Experiences in Children with Arthritis: An Analysis of the National Survey of Children’s Health

    Tamar Rubinstein1, Danielle R. Bullock2, Kaveh Ardalan3, Wenzhu B. Mowrey4, Nicole Brown5 and Ruth E K Stein6, 1Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, 2Pediatrics, University of Minnesota, Minneapolis, MN, 3Division of Rheumatology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, 4Albert Einstein College of Medicine, Bronx, NY, 5Albert Einstein College of Medicine/ Children's Hospital at Montefiore, Bronx, NY, 6Pediatrics, Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Adverse Childhood Experiences (ACEs) are associated with increased risk of chronic disease and poorer health in children and adults. Emerging data suggest an association…
  • Abstract Number: 915 • 2018 ACR/ARHP Annual Meeting

    The Association between Structural and Symptomatic Progression in Knee Osteoarthritis

    Jamie E. Collins1, Swastina Shrestha2 and Elena Losina3, 1Department of Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 3Harvard Medical School, Boston, MA

    Background/Purpose:  The link between progression of structure and symptoms in knee osteoarthritis (OA) is not well understood. This uncertainty hinders the effort to develop therapies…
  • Abstract Number: 916 • 2018 ACR/ARHP Annual Meeting

    Integrative Analysis of Multi-Omics Data in an Ethnically Diverse Lupus Cohort Identifies Distinct Molecular Subtypes of SLE

    Cristina Lanata1, Ishan Paranjpe2, Joanne Nitiham3, Kimberly Taylor4, Brooke Rhead5, Milena Gianfrancesco6, Lisa Barcellos7, Louise Murphy8, Patricia Katz9, Laura Trupin6, Jinoos Yazdany2, Maria Dall'Era2, Marina Sirota10 and Lindsey A. Criswell9, 1Rosalind Russell Medical Research Center for Arthritis, Department of Medicine, Division of Rheumatology, University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, CA, 4University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 5University of California, Berkeley, Berkeley, CA, 6Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 7School of Public Health, UC Berkeley, Berkeley, CA, 8Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 9University of California San Francisco, San Francisco, CA, 10Pediatrics, Institute for Computational Health Sciences, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Systemic Lupus Erythematous (SLE) is a chronic autoimmune disease with heterogeneous disease manifestations and outcomes. We aimed to define how molecular differences underlie this…
  • Abstract Number: 917 • 2018 ACR/ARHP Annual Meeting

    Type 1 Interferon Levels Correlates with Age of Diagnosis and Ethnicity in Systemic Lupus Erythematous

    Majid Abedi1, Lilian Borisov2, Allison Doyle1, Francisco Flores2, June Fujimoto2, Aviva Jacobs1, Pramod Naranatt1, Liuliu Pan2, William Ricketts3, Jacob Spangler1, Kristen Warren2 and Robert Terbrueggen2, 1DxTerity, Rancho Domiquez, CA, 2DxTerity, Rancho Dominguez, CA, 3Clinical Operations, DxTerity, Rancho Domiquez, CA

    Background/Purpose: Low cost, patient-administered, “from home” genomic tests for monitoring disease activity and therapy response could revolutionize treatment and management of Systemic Lupus Erythematous (SLE)…
  • Abstract Number: 918 • 2018 ACR/ARHP Annual Meeting

    A Novel Familial RELA Truncation Is Associated with Behçet’s-like Mucocutaneous Ulceration Syndrome

    Emma Dorris1, Fahd Adeeb2, Eoin Cummins3, Sinisa Savic4, Sandy Fraser5 and Anthony G. Wilson6, 1UCD Conway Institute,, UCD Centre for Arthritis Research, Dublin 4, Ireland, 2Department of Rheumatology, University of Limerick, LIMERICK, Ireland, 3School of Medicine, Dublin 4, Ireland, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, The University of Leeds, Leeds, United Kingdom, 5Rheumatology, Croom Orthopedic Hospital, Ireland, Limerick, Ireland, 6UCD School of Medicine and Medical Science, Conway Institute, University College Dublin, Dublin, Ireland

    Background/Purpose: Bechet’s disease (BD) is a heterogeneous multifactorial auto-inflammatory condition characterized by recurrent episodes of oral and genital ulceration, uveitis and skin lesions, with less…
  • Abstract Number: 919 • 2018 ACR/ARHP Annual Meeting

    A Machine Learning Classifier for Assigning Individual Patients with Systemic Sclerosis to Intrinsic Molecular Subsets

    Jennifer Franks1, Viktor Martyanov1, Guoshuai Cai2, Yue Wang3, Tammara A. Wood1 and Michael L. Whitfield4, 1Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Environmental Health Sciences, Arnold School of Public Health at University of South Carolina, Columbia, SC, 3Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 4Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, NH

    Background/Purpose: High-throughput gene expression profiling of skin biopsies from patients with systemic sclerosis (SSc) has identified four “intrinsic” gene expression subsets conserved across multiple cohorts…
  • Abstract Number: 920 • 2018 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Patient-Specific Therapeutic Target Identification Using Integrative Epigenetic Profiling

    Richard Ainsworth1, Kai Zhang2, Lina Zheng3, Gary S. Firestein4 and Wei Wang5, 1UC San Diego, La Jolla, CA, 2UCSD School of Engineering, San Diego, CA, 3Chemistry and Biochemistry, UC San Diego, La Jolla, CA, 4Medicine, UC San Diego, La Jolla, CA, 5Chemistry and Biochemistry, University of California San Diego, La Jolla, CA

    Background/Purpose: To explain the complex regulatory changes associated with RA synovitis and the diversity of responses to targeted therapies, we developed and applied a novel…
  • « Previous Page
  • 1
  • …
  • 1063
  • 1064
  • 1065
  • 1066
  • 1067
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology